Rocket
Premium
Excel Add-In
International
Tools
Dashboard
Screener
Spinoffs
IPOs
Register
Alerts
Sign In
Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders
Income Statement
Balance Sheet
Cash Flow Statement
Segments
Common Size IS
Op Efficiency
Credit Analysis
Baxalta Inc (BXLT) >
Segments
Immunoglobulin Therapies
Chart
Annual
|
Quarterly
|
TTM
In millions, except per share items
Dec-31-15
Dec-31-14
Dec-31-13
10-K
10-K
10-K
Revenues
1,750
1,677
1,616
Revenue growth
4.4%
3.8%
Revenue Mix
28.5%
28.2%
29.1%
Rocket Data Systems, Inc. © 2019 |
Contact Us
|
Data Disclaimer
|
Terms of Use
|
Privacy